Skip to main content
Clinical Trials/NCT06551714
NCT06551714
Recruiting
Not Applicable

The Effect of Neurophysiological Facilitation Techniques on Pulmonary Function, Respiratory Muscle Strength and Functional Capacity in The Early Stage After Open Heart Surgery

Dogus Universitesi1 site in 1 country32 target enrollmentJanuary 1, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Open Heart Surgery
Sponsor
Dogus Universitesi
Enrollment
32
Locations
1
Primary Endpoint
Expiratory muscle strength
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

In this study, researchers aimed to investigate effects of neurophysiological facilitation on functional capacity and respiratory parameters of patients who underwent open heart surgery.

Do neurophysiological facilitation techniques improve individuals' respiratory parameters more than phase 1 cardiac rehabilitation?

Do neurophysiological facilitation techniques improve individuals' functional capacity more than phase 1 cardiac rehabilitation?

Researchers will apply phase 1 cardiac rehabilitation to both groups to see the effectiveness of neurophysiological facilitation techniques.

Detailed Description

In this study, researchers aimed to investigate effects of neurophysiological facilitation on functional capacity and respiratory parameters of patients who underwent open heart surgery. The study was performed on 32 patients who underwent open heart surgery. Patients divided into two groups which study group (n=18) and control group (n=14). Range of motion, breathing and mobilization exercises within the scope of phase 1 cardiac rehabilitation program were applied to the control group; in addition to the phase 1 cardiac rehabilitation program, neurophysiological facilitation techniques (perioral stimulation, intercostal tension, anterior basal lift, vertebral pressure, moderate manual pressure and abdominal co-contraction) were applied to the study group. Sociodemographic features and disease-specific findings were recorded on the first postoperative day . Vital signs, functional capacity, pulmonary function, fatigue and dyspnea of every patient were recorded before and after each treatment on the first four postoperative days. Functional capacity was evaluated using Timed Up and Go (TUG) test and 2-Minutes Walking test (2MWT). Pulmonary function was examined using a peak flow meter and respiratory muscle strength was measured using an intraoral pressure measurement device. In addition, fatigue and dyspnea perception was measured using Modified Borg Scale. Before the first day treatment and after the last day treatment of the four-day treatment, patients' fatigue severity were assessed with using Fatigue Severity Scale (FSS), anxiety and depression level with using Hospital Anxiety Depression Scale (HADS), fear of movement with using TAMPA Kinesiophobia Scale and life quality with using the Minnesota Heart Failure Questionnaire. Before each treatment chest circumference measurements were taken, and the perceived pain severity was recorded using Visual Analog Scale (VAS).

Registry
clinicaltrials.gov
Start Date
January 1, 2024
End Date
November 1, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Feyza Merakli

lecturer

Dogus Universitesi

Eligibility Criteria

Inclusion Criteria

  • Having open heart surgery for the first time,
  • Being between the ages of 18-75,
  • Being fully cooperative

Exclusion Criteria

  • Having facial, sternum and rib fractures,
  • Having chronic renal failure,
  • Development of cerebrovascular accident,
  • Having cognitive dysfunction,
  • Development of deep vein thrombosis in the post-operative period,
  • Having neuromuscular disease,
  • Having an orthopedic disability,
  • Intubation time longer than 24 hours,
  • Staying in intensive care for more than 48 hours

Outcomes

Primary Outcomes

Expiratory muscle strength

Time Frame: After and before treatment on each day of treatment, up to 3 month

Maximum Expiratory Pressure (MEP) - pressure

İnspiratory muscle strength

Time Frame: Before and after treatment on each day of treatment, up to 3 month

Maximum Inspiratory Pressure (MIP) - pressure

Time Up and Go (TUG)

Time Frame: first day of treatment before treatment and last day of treatment after treatment, up to 3 month

The person gets up from the chair, walks 3 meters, comes back and sits on the chair. - minute

Vital sign

Time Frame: Before and after treatment on each day of treatment, up to 3 month

Oxygen saturation

2 Minute Walk Test

Time Frame: Before treatment on the first day of treatment and after treatment on the last day of treatment, up to 3 month

It is walking as fast as the person can for 2 minutes without any assistance, at a safe distance of 30 meters. - meter

Life quality

Time Frame: Before treatment on the first day of treatment and after treatment on the last day of treatment, up to 3 month

The Minnesota Living with Heart Failure Questionnaire

Respiratory frequency

Time Frame: Before and after treatment on each day, up to 3 month

Number of times a person inhales and exhales in 1 minute. - number

Blood pressure

Time Frame: Before and after treatment on day of treatment, up to 3 month

Blood pressure is the pressure of blood within the arteries of the circulatory system. - pressure

Depression

Time Frame: Before treatment on the first day of treatment and after treatment on last day of treatment, up to 3 month

Beck's depression inventory

Heart rate

Time Frame: Before and after treatment on each day of treatment, up to 3 month

Number of times a person heart rate in 1 minute. - number

Symptom

Time Frame: Before and after treatment on each day of treatment, up to 3 month

Dyspnea

Study Sites (1)

Loading locations...

Similar Trials